New Publications from CBM² Members, May 2025
Last month, two meeting abstracts, co-authored by Dr. Godwin, were presented at the 2025 ASCO Annual Meeting. These were later published in the Journal of Clinical Oncology. Links to the full texts are listed below:
- Assessment of ctDNA somatic homologous recombination deficiency (HRD) in triple-negative breast cancer (TNBC) from SWOG S1416 trial. From: ASCO Publications, Journal of Clinical Oncology
- Results of a phase I study of alpelisib and sacituzumab govitecan (SG) in patients with HER2-negative metastatic breast cancer (MBC). From: ASCO Publications, Journal of Clinical Oncology